C
Cytokinetics
Cytokinetics | Muscle Biology Therapies | Home
At a glance
- Status
- Listed
- Founded
- 1998
- Headquarters
- South San Francisco, United States
- Listing
- IPO 2004
- Sector
- Biotech & Life Sciences
- Power Law
- Decacorn$10B+ valuation tier
Knowledge graph
More headlines
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A1 investor entered at this stage
Series B and later3 investors entered at this stage
- SFSevin Rosen Funds
- VGVale Group
- DUDuke University
Source: Dealroom Talent Intelligence.
Global footprint
across markets
Patents
93 active patent families included in this estimate.
A patent family groups patent filings for the same invention. Source: Dealroom · PatSnap.
Investments and acquisitions
Disclosed deals where Cytokinetics was the backer or acquirer, 2023–2025. Toggle between venture rounds, M&A, or both. The map below is grouped by the target company's sector — the colored pill on each chip is the round type.
4 deals across Cytokinetics's capital deployment.
Where the deals concentrate by sector, stage, and decade.
Cytokinetics's portfolio, mapped.
Market sentiment
An AI-synthesised read of the highest-engagement posts about Cytokinetics on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Cytokinetics on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.
